Our study also indicated that the treatment of chelerythrine downregulated CD36 and IL-1β as well as inflammation related genes like IFNγ and TNFα, which are of great benefits for the treatment of diabetes (Supplementary Figure 4). This evidence concerns the gene TNF and diabetes mellitus.